Proactive Safety Monitoring of Biosimilars: A Comprehensive Approach Combining Immunogenicity, Big Data, and Global Standards.
The introduction of biosimilars into the marketplace has allowed more patients access to biological drugs through the development of alternative, but highly similar biological products. However, the complex nature of biosimilars in terms of structure, manufacture, and risk of immunogenicity requires strong and continua...